Follow The Filings

HLI Houlihan Lokey

Houlihan Lokey earnings company data as of 4:45 AM ET 10/9

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS 1.60 — —
Rev — — —

Insider trades

Open-market buys and sales by HLI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All HLI insider trades
  • $501K bought by 1 insider
  • $1.9M sold by 3 insiders outside a trading plan
  • $159K sold by 1 insider under 10b5-1 plans
  1. Christopher M Crain General Counsel
    Sale
    $140K 1,000 shares at $140.15 100% of stake
    Traded Sep 10 Filed Sep 10
  2. J Lindsey Alley CFO
    Buy
    $501K 4,020 shares at $124.52 New stake
    Traded Aug 3 Filed Aug 5
  3. Scott L Beiser Chair
    Sale
    $941K 6,265 shares at $150.26 100% of stake
    Traded May 21 Filed May 21
  4. Christopher M Crain General Counsel
    Planned sale
    $72K 500 shares at $143.40 100% of stake
    Traded Apr 1 Filed Apr 2
  5. Robert A Schriesheim Director
    Sale
    $854K 5,000 shares at $170.86 15% of stake
    Traded Feb 6 Filed Feb 10
  6. Christopher M Crain General Counsel
    Planned sale
    $87K 500 shares at $174.17 100% of stake
    Traded Jan 2 Filed Jan 5

Also filed in the last 12 months, not counted as buying or selling: 7 stock grants, 7 conversions, and 3 gifts.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
8-K 5.02
8-K 5.02,5.07,7.01,9.01
8-K 5.02
DEFA14A
424B7
8-K 8.01,9.01
10-Q
8-K 2.02,9.01
DEF 14A
DEFA14A
10-K
SCHEDULE 13G/A —
8-K 2.02,9.01
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G/A —
424B7
8-K 8.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.